ARTICLE | Company News
Astellas, Tolmar sales and marketing update
January 24, 2011 8:00 AM UTC
Tolmar granted Astellas' Astellas Pharma Europe Ltd. subsidiary marketing rights to Eligard leuprolide acetate in China, Taiwan, Thailand, Hong Kong, the Philippines, Indonesia, the Middle East, North Africa and Commonwealth of Independent States to treat prostate cancer. Further terms were not disclosed. ...